GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $150,000 | -21.1% | 10,237 | -77.8% | 0.00% | 0.0% |
| Q1 2020 | $190,000 | +17.3% | 46,187 | +37.1% | 0.00% | 0.0% |
| Q4 2019 | $162,000 | +23.7% | 33,700 | +55.3% | 0.00% | 0.0% |
| Q3 2019 | $131,000 | +12.9% | 21,700 | +20.6% | 0.00% | 0.0% |
| Q2 2019 | $116,000 | -3.3% | 18,000 | +5.9% | 0.00% | 0.0% |
| Q1 2019 | $120,000 | +55.8% | 17,000 | +6.2% | 0.00% | – |
| Q4 2018 | $77,000 | -24.5% | 16,000 | +14.3% | 0.00% | – |
| Q3 2018 | $102,000 | -11.3% | 14,000 | -22.2% | 0.00% | -100.0% |
| Q2 2018 | $115,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,443,400 | $5,947,000 | 1.68% |
| Casdin Capital, LLC | 3,365,000 | $13,864,000 | 1.47% |
| Lyon Street Capital, LLC | 191,656 | $790,000 | 1.26% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,489,055 | $14,375,000 | 0.71% |
| Portolan Capital Management | 893,090 | $3,680,000 | 0.55% |
| Eversept Partners, LP | 524,257 | $2,159,939 | 0.54% |
| Bullseye Asset Management LLC | 78,961 | $325,000 | 0.39% |
| Parkman Healthcare Partners LLC | 200,000 | $824,000 | 0.38% |
| Granite Investment Partners, LLC | 757,878 | $3,122,000 | 0.20% |
| Bellevue Group AG | 2,411,926 | $9,937,000 | 0.19% |